54 related articles for article (PubMed ID: 10228796)
1. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
2. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back.
Berghella AM; Pellegrini P; Del Beato T; Marini M; Tomei E; Adorno D; Casciani CU
Cancer Immunol Immunother; 1998 Jan; 45(5):241-9. PubMed ID: 9439647
[TBL] [Abstract][Full Text] [Related]
3. Increased serum soluble interleukin-2 receptor levels in dermatomyositis are associated with Th17/Treg immune imbalance.
Xie Y; Zhang T; Su R; Liu L; Jiang L; Xue H; Gao C; Li X; Wang C
Clin Exp Med; 2023 Nov; 23(7):3605-3617. PubMed ID: 37528249
[TBL] [Abstract][Full Text] [Related]
4. 41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases.
Atanackovic D; Nierhaus A; Neumeier M; Hossfeld DK; Hegewisch-Becker S
Cancer Immunol Immunother; 2002 Dec; 51(11-12):603-13. PubMed ID: 12439605
[TBL] [Abstract][Full Text] [Related]
5. The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation.
Huang A; Quinn H; Glover C; Henderson DC; Allen-Mersh TG
Cancer Immunol Immunother; 2002 Mar; 51(1):53-7. PubMed ID: 11845260
[TBL] [Abstract][Full Text] [Related]
6. The signature and predictive value of immune parameters in patients with secondary hemophagocytic lymphohistiocytosis.
Bai H; Wang Y; Shen L; Luo Y; Tang G; Wang F; Sun Z; Hou H
Immunobiology; 2023 Nov; 228(6):152759. PubMed ID: 37939638
[TBL] [Abstract][Full Text] [Related]
7. Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis.
Sise ME; Wang Q; Seethapathy H; Moreno D; Harden D; Smith RN; Rosales IA; Colvin RB; Chute S; Cornell LD; Herrmann SM; Fadden R; Sullivan RJ; Yang NJ; Barmettler S; Wells S; Gupta S; Villani AC; Reynolds KL; Farmer J
J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657813
[TBL] [Abstract][Full Text] [Related]
8. Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4).
Elkord E; Dangoor A; Burt DJ; Southgate TD; Daayana S; Harrop R; Drijfhout JW; Sherlock D; Hawkins RE; Stern PL
Cancer Immunol Immunother; 2009 Oct; 58(10):1657-67. PubMed ID: 19221742
[TBL] [Abstract][Full Text] [Related]
9. Self-reported sleep duration, white blood cell counts and cytokine profiles in European adolescents: the HELENA study.
Pérez de Heredia F; Garaulet M; Gómez-Martínez S; Díaz LE; Wärnberg J; Androutsos O; Michels N; Breidenassel C; Cuenca-García M; Huybrechts I; Gottrand F; Ferrari M; Santaliestra-Pasías AM; Kafatos A; Molnár D; Sjöstrom M; Widhalm K; Moreno LA; Marcos A;
Sleep Med; 2014 Oct; 15(10):1251-8. PubMed ID: 25156749
[TBL] [Abstract][Full Text] [Related]
10. Systemic immunological profile of children with B-cell acute lymphoblastic leukemia: performance of cell populations and soluble mediators as serum biomarkers.
Carvalho MPSS; Magalhães-Gama F; Loiola BP; Neves JCF; Araújo ND; Silva FS; Catão CLS; Alves EB; Pimentel JPD; Barbosa MNS; Fraiji NA; Teixeira-Carvalho A; Martins-Filho OA; Costa AG; Malheiro A
Front Oncol; 2023; 13():1290505. PubMed ID: 38107068
[TBL] [Abstract][Full Text] [Related]
11. The immune inflammation factors associated with disease severity and poor prognosis in patients with COVID-19: A retrospective cohort study.
Kang Y; Lu S; Zhong R; You J; Chen J; Li L; Huang R; Xie Y; Chen F; Chen J; Chen L
Heliyon; 2024 Jan; 10(1):e23583. PubMed ID: 38173531
[TBL] [Abstract][Full Text] [Related]
12. Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia.
Malashenkova IK; Krynskiy SA; Ogurtsov DP; Hailov NA; Zakharova NV; Bravve LV; Kaydan MA; Chekulaeva EI; Andreyuk DS; Ushakov VL; Didkovsky NA; Kostyuk GP
Consort Psychiatr; 2021 Mar; 2(1):19-31. PubMed ID: 38601098
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer therapy affects the expression of antineonatal Nav1.5 antibodies in the serum of patients with breast cancer.
Rajaratinam H; Rasudin NS; Al Astani TAD; Mokhtar NF; Yahya MM; Zain WZW; Asma-Abdullah N; Fuad WEM
Oncol Lett; 2021 Feb; 21(2):108. PubMed ID: 33376541
[TBL] [Abstract][Full Text] [Related]
14. Salivary Concentrations of Chemerin, α-Defensin 1, and TNF-α as Potential Biomarkers in the Early Diagnosis of Colorectal Cancer.
Waniczek D; Świętochowska E; Śnietura M; Kiczmer P; Lorenc Z; Muc-Wierzgoń M
Metabolites; 2022 Jul; 12(8):. PubMed ID: 36005576
[TBL] [Abstract][Full Text] [Related]
15. Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.
Song X; Traub B; Shi J; Kornmann M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450900
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein and risk of colorectal adenomas or serrated polyps: a prospective study.
Crockett SD; Mott LA; Barry EL; Figueiredo JC; Burke CA; Baxter GJ; Sandler RS; Baron JA
Cancer Prev Res (Phila); 2014 Nov; 7(11):1122-7. PubMed ID: 25145487
[TBL] [Abstract][Full Text] [Related]
17. Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy.
Song G; Wang X; Jia J; Yuan Y; Wan F; Zhou X; Yang H; Ren J; Gu J; Lyerly HK
Cancer Immunol Immunother; 2013 Jun; 62(6):1123-30. PubMed ID: 23604172
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients.
Tsavaris N; Voutsas IF; Kosmas C; Gritzapis AD; Baxevanis CN
Invest New Drugs; 2012 Feb; 30(1):395-402. PubMed ID: 20820907
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein as an acute phase protein in cancer patients.
Bolayirli M; Turna H; Orhanoğlu T; Ozaras R; Ilhan M; Ozgüroğlu M
Med Oncol; 2007; 24(3):338-44. PubMed ID: 17873311
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
